AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm’s AI model of the immune ...

IT services major Accenture unveiled a $4 billion share buyback on Thursday, closing the fourth quarter with ...

Scope 3 emissions represent a significant challenge for companies aiming to enhance their ESG performance. But because ...

Careful compliance is among the non-negotiables for building customer trust in banks; tech sprawl runs a real risk of harming ...

Global businesses focussed on sustainability need to empower local communities to take local action as this results in more ...